Extracellular HMGB1 regulates multi-walled carbon nanotube-induced inflammation in vivo

References

• Beamer CA, Girtsman TA, Seaver BP, Finsaas KJ, Migliaccio CT, Perry VK, et al. 2013. IL-33 mediates multi-walled carbon nanotube (MWCNT)-induced airway hyper-reactivity via the mobilization of innate helper cells in the lung. Nanotoxicology 7:1070–81
   PubMed Web of Science ®Google Scholar
• Cesta MF, Ryman-Rasmussen JP, Wallace DG, Masinde T, Hurlburt G, Taylor AJ, Bonner JC 2010. Bacterial lipopolysaccharide enhances PDGF signaling and pulmonary fibrosis in rats exposed to carbon nanotubes. Am J Respir Cell Mol Biol 43:142–51
   PubMed Web of Science ®Google Scholar
• Chen GY, Nunez G. 2010. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol 10:826–37
   PubMed Web of Science ®Google Scholar
• Dave SH, Tilstra JS, Matsuoka K, Li F, Demarco RA, Beer-Stolz D, Sepulveda AR, et al. 2009. Ethyl pyruvate decreases HMGB1 release and ameliorates murine colitis. J Leukoc Biol 86:633–43
   PubMed Web of Science ®Google Scholar
• Dupont N, Jiang S, Pilli M, Ornatowski W, Bhattacharya D, Deretic V. 2011. Autophagy-based unconventional secretory pathway for extracellular delivery of IL-1beta. EMBO J 30:4701–11
   PubMed Web of Science ®Google Scholar
• Gardella S, Andrei C, Ferrera D, Lotti LV, Torrisi MR, Bianchi ME, Rubartelli A. 2002. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep 3:995–1001
   PubMed Web of Science ®Google Scholar
• Ghonime MG, Shamaa OR, Das S, Eldomany RA, Fernandes-Alnemri T, Alnemri ES, et al. 2014. Inflammasome priming by lipopolysaccharide is dependent upon ERK signaling and proteasome function. J Immunol 192:3881–8
   PubMed Web of Science ®Google Scholar
• Girtsman TA, Beamer CA, Wu N, Buford M, Holian A. 2012. IL-1R signalling is critical for regulation of multi-walled carbon nanotubes-induced acute lung inflammation in C57Bl/6 mice. Nanotoxicology 8:17–27
   PubMed Web of Science ®Google Scholar
• Glista-Baker EE, Taylor AJ, Sayers BC, Thompson EA, Bonner JC. 2014. Nickel nanoparticles cause exaggerated lung and airway remodeling in mice lacking the T-box transcription factor, TBX21 (T-bet). Particle Fibre Toxicol 11:7. doi: 10.1186/1743-8977-11-7
   PubMed Web of Science ®Google Scholar
• Hamada N, Maeyama T, Kawaguchi T, Yoshimi M, Fukumoto J, Yamada M, et al. 2008. The role of high mobility group box1 in pulmonary fibrosis. Am J Respir Cell Mol Biol 39:440–7
   PubMed Web of Science ®Google Scholar
• Hamilton RF, Buford MC, Wood MB, Arnone B, Morandi M, Holian A. 2007. Engineered carbon nanoparticles alter macrophage immune function and initiate airway hyper-responsiveness in the BALB/c mouse model. Nanotoxicology 1:104–17
   Web of Science ®Google Scholar
• Hamilton RF Jr, Buford M, Xiang C, Wu N, Holian A. 2012. NLRP3 inflammasome activation in murine alveolar macrophages and related lung pathology is associated with MWCNT nickel contamination. Inhal Toxicol 24:995–1008
   PubMed Web of Science ®Google Scholar
• Hamilton RFJ, Wu Z, Mitra S, Shaw PK, Holian A. 2013. Effect of MWCNT size, carboxylation, and purification on in vitro and in vivo toxicity, inflammation and lung pathology. Part Fibre Toxicol 10:57. doi: 10.1186/1743-8977-10-57
   PubMed Web of Science ®Google Scholar
• Hreggvidsdottir HS, Ostberg T, Wahamaa H, Schierbeck H, Aveberger AC, Klevenvall L, et al. 2009. The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation. J Leukoc Biol 86:655–62
   PubMed Web of Science ®Google Scholar
• Kew RR, Penzo M, Habiel DM, Marcu KB 2012. The IKKalpha-dependent NF-kappaB p52/RelB noncanonical pathway is essential to sustain a CXCL12 autocrine loop in cells migrating in response to HMGB1. J Immunol 188:2380–6
   PubMed Web of Science ®Google Scholar
• Kim JY, Park JS, Strassheim D, Douglas I, Diaz del Valle F, Asehnoune K, et al. 2005. HMGB1 contributes to the development of acute lung injury after hemorrhage. Am J Physiol Lung Cell Mol Physiol 288:L958–65
   PubMed Web of Science ®Google Scholar
• Lacher SE, Johnson C, Jessop F, Holian A, Migliaccio CT 2010. Murine pulmonary inflammation model: a comparative study of anesthesia and instillation methods. Inhal Toxicol 22:77–83
   PubMed Web of Science ®Google Scholar
• Lamkanfi M, Sarkar A, vande Walle L, Vitari AC, Amer AO, Wewers MD, et al. 2010. Inflammasome-dependent release of the alarmin HMGB1 in endotoxemia. J Immunol 185:4385–92
   PubMed Web of Science ®Google Scholar
• Leblanc PM, Doggett TA, Choi J, Hancock MA, Durocher Y, Frank F, et al. 2014. An Immunogenic Peptide in the A-box of HMGB1 Protein Reverses Apoptosis-induced Tolerance through RAGE Receptor. J Biol Chem 289:7777–86
   PubMed Web of Science ®Google Scholar
• Liou TG, Adler FR, Keogh RH, Li Y, Jensen JL, Walsh W, et al. 2012. Sputum biomarkers and the prediction of clinical outcomes in patients with cystic fibrosis. PLoS One 7:e42748
   PubMed Web of Science ®Google Scholar
• Martinon F, Burns K, Tschopp J. 2002. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 10:417–26
   PubMed Web of Science ®Google Scholar
• Mercer RR, Hubbs AF, Scabilloni JF, Wang L, Battelli LA, Friend S, et al. 2011. Pulmonary fibrotic response to aspiration of multi-walled carbon nanotubes. Particle Fibre Toxicol 8:21. doi: 10.1186/1743-8977-8-21
   PubMed Web of Science ®Google Scholar
• Mercer RR, Scabilloni JF, Hubbs AF, Battelli LA, McKinney W, Friend S, et al. 2013. Distribution and fibrotic response following inhalation exposure to multi-walled carbon nanotubes. Particle Fibre Toxicol 10:33. doi: 10.1186/1743-8977-10-33
   PubMed Web of Science ®Google Scholar
• Palomaki J, Valimaki E, Sund J, Vippola M, Clausen PA, Jensen KA, et al. 2011. Long, needle-like carbon nanotubes and asbestos activate the NLRP3 inflammasome through a similar mechanism. ACS Nano 5:6861–70
   PubMed Web of Science ®Google Scholar
• Park JS, Gamboni-Robertson F, He Q, Svetkauskaite D, Kim JY, Strassheim D, et al. 2006. High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol 290:C917–24
   PubMed Web of Science ®Google Scholar
• Pisetsky DS. 2014. The Expression of HMGB1 on microparticles released during cell activation and cell death in vitro and in vivo. Mol Med 20:158–63
   PubMed Web of Science ®Google Scholar
• Porter D, Sriram K, Wolfarth M, Jefferson A, Schwegler-BERRY D, Andrew M, Castranova V. 2008. A biocompatible medium for nanoparticle dispersion. Nanotoxicology 2:144–154
   Web of Science ®Google Scholar
• Scaffidi P, Misteli T, Bianchi ME 2002. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418:191–5
   PubMed Web of Science ®Google Scholar
• Schwartz DA 2001. Inhaled endotoxin, a risk for airway disease in some people. Respir Physiol 128:47–55
   PubMedGoogle Scholar
• Sha Y, Zmijewski J, Xu Z, Abraham E. 2008. HMGB1 develops enhanced proinflammatory activity by binding to cytokines. J Immunol 180:2531–7
   PubMed Web of Science ®Google Scholar
• Shim EJ, Chun E, Lee HS, Bang BR, Kim TW, Cho SH, et al. 2012. The role of high-mobility group box-1 (HMGB1) in the pathogenesis of asthma. Clin Exp Allergy 42:958–65
   PubMed Web of Science ®Google Scholar
• Stros M. 2010. HMGB proteins: interactions with DNA and chromatin. Biochim Biophys Acta 1799:101–13
   PubMed Web of Science ®Google Scholar
• Ueno H, Matsuda T, Hashimoto S, Amaya F, Kitamura Y, Tanaka M, et al. 2004. Contributions of high mobility group box protein in experimental and clinical acute lung injury. Am J Respir Crit Care Med 170:1310–16
   PubMed Web of Science ®Google Scholar
• Ullah MA, Loh Z, Gan WJ, Zhang V, Yang H, Li JH, et al. 2014. Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation. J Allergy Clin Immunol . [Epub ahead of print]. doi: 10.1016/j.jaci.2013.12.1035
   PubMed Web of Science ®Google Scholar
• van Zoelen MA, Ishizaka A, Wolthuls EK, Choi G, van der Poll T, Schultz MJ 2008. Pulmonary levels of high-mobility group box 1 during mechanical ventilation and ventilator-associated pneumonia. Shock 29:441–5
   PubMed Web of Science ®Google Scholar
• Venereau E, Casalgrandi M, Schiraldi M, Antoine DJ, Cattaneo A, de Marchis F, et al. 2012. Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release. J Exp Med 209:1519–28
   PubMed Web of Science ®Google Scholar
• Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, et al. 1999. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285:248–51
   PubMed Web of Science ®Google Scholar
• Wang H, Yang H, Tracey KJ 2004. Extracellular role of HMGB1 in inflammation and sepsis. J Intern Med 255:320–31
   PubMed Web of Science ®Google Scholar
• Willingham SB, Allen IC, Bergstralh DT, Brickey WJ, Huang MT, Taxman DJ, et al. 2009. NLRP3 (NALP3, Cryopyrin) facilitates in vivo caspase-1 activation, necrosis, and HMGB1 release via inflammasome-dependent and -independent pathways. J Immunol 183:2008–15
   PubMed Web of Science ®Google Scholar
• Yang H, Hreggvidsdottir HS, Palmblad K, Wang H, Ochani M, Li J, et al. 2010a. A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc Natl Acad Sci USA 107:11942–7
   PubMed Web of Science ®Google Scholar
• Yang H, Rivera Z, Jube S, Nasu M, Bertino P, Goparaju C, et al. 2010b. Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation. Proc Natl Acad Sci USA 107:12611–16
   PubMed Web of Science ®Google Scholar
• Yang H, Lundback P, Ottosson L, Erlandsson-Harris H, Venereau E, Bianchi ME, et al. 2012. Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1). Mol Med 18:250–9
   PubMed Web of Science ®Google Scholar